Welcoming Our new CEO

Conroy Medical, a globally active and innovative MedTech company in transfusion medicine and part of the Indutrade Group, is pleased to announce the appointment of Maria Lundman Hedberg as the company’s new CEO, effective immediately.

Maria brings over 20 years of experience in the MedTech sector, most recently as CEO of Orkla Wound Care, a company within wound care and first aid (MDR Class I, IIa, and III). Throughout her career, Maria has led businesses and teams toward operational excellence with a strong focus on continuous improvement, change management, and growth initiatives. Her expertise in strategic planning, business development, and innovation is highly relevant as Conroy Medical continues to develop and expand within the field of transfusion medicine. Conroy Medical is well-positioned to accelerate its global expansion and broaden its offering in transfusion medicine through innovations and solutions of the highest technical quality.

“I am honored to take on the role of CEO at Conroy Medical,” says Maria Lundman Hedberg, continuing, “Conroy is a very promising company, and the team here has built a solid business as a manufacturer and distributor of high-quality products within transfusion medicine. I look forward to working together with Conroy’s skilled and dedicated employees to continue developing and selling new, innovative solutions to our customers. Together, I feel confident that we will open up new opportunities and realize increased growth and global expansion.”

In connection with Maria’s appointment as CEO, Nicklas Lundman will step down. Nicklas, who has led the company with dedication and distinction for eight years, has been a key contributor in building today’s Conroy—with strong, high-quality products, important customer relationships, and a highly capable organization.
Maria assumes the position effective immediately, and during a transition period, the outgoing CEO, Nicklas Lundman, will work closely with her to introduce her to the business and ensure that all ongoing projects and initiatives continue to move forward.